Wockhardt gets DCGI approval for two new antibiotics
EMROK (IV) and EMROK-O (Oral) have got approval for acute bacterial skin and skin structure infections including diabetic foot…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.